Skip to main content
Erschienen in: Journal of Cancer Survivorship 1/2023

16.11.2021 | Review

Effectiveness and implementation of models of cancer survivorship care: an overview of systematic reviews

verfasst von: Raymond J. Chan, Fiona Crawford-Williams, Megan Crichton, Ria Joseph, Nicolas H. Hart, Kristi Milley, Paige Druce, Jianrong Zhang, Michael Jefford, Karolina Lisy, Jon Emery, Larissa Nekhlyudov

Erschienen in: Journal of Cancer Survivorship | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To critically assess the effectiveness and implementation of different models of post-treatment cancer survivorship care compared to specialist-led models of survivorship care assessed in published systematic reviews.

Methods

MEDLINE, CINAHL, Embase, and Cochrane CENTRAL databases were searched from January 2005 to May 2021. Systematic reviews that compared at least two models of cancer survivorship care were included. Article selection, data extraction, and critical appraisal were conducted independently by two authors. The models were evaluated according to cancer survivorship care domains, patient and caregiver experience, communication and decision-making, care coordination, quality of life, healthcare utilization, costs, and mortality. Barriers and facilitators to implementation were also synthesized.

Results

Twelve systematic reviews were included, capturing 53 primary studies. Effectiveness for managing survivors’ physical and psychosocial outcomes was found to be no different across models. Nurse-led and primary care provider-led models may produce cost savings to cancer survivors and healthcare systems. Barriers to the implementation of different models of care included limited resources, communication, and care coordination, while facilitators included survivor engagement, planning, and flexible services.

Conclusions

Despite evidence regarding the equivalent effectiveness of nurse-led, primary care-led, or shared care models, these models are not widely adopted, and evidence-based recommendations to guide implementation are required. Further research is needed to address effectiveness in understudied domains of care and outcomes and across different population groups.

Implications for Cancer Survivors

Rather than aiming for an optimal “one-size fits all” model of survivorship care, applying the most appropriate model in distinct contexts can improve outcomes and healthcare efficiency.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Nekhlyudov, L., et al., Developing a quality of cancer survivorship care framework: implications for clinical care, research, and policy. JNCI: Journal of the National Cancer Institute. 2019; 111(11): 1120–1130. https://doi.org/10.1093/jnci/djz089 Nekhlyudov, L., et al., Developing a quality of cancer survivorship care framework: implications for clinical care, research, and policy. JNCI: Journal of the National Cancer Institute. 2019; 111(11): 1120–1130. https://​doi.​org/​10.​1093/​jnci/​djz089
4.
Zurück zum Zitat Hewitt M, Greenfield S, Stovall E. From cancer patient to cancer survivor: lost in transition. Washington, DC: National Academies Press; 2005. Hewitt M, Greenfield S, Stovall E. From cancer patient to cancer survivor: lost in transition. Washington, DC: National Academies Press; 2005.
8.
Zurück zum Zitat Alfano, C.M., et al., Implementing personalized pathways for cancer follow-up care in the United States: Proceedings from an American Cancer Society–American Society of Clinical Oncology summit. CA: A Cancer Journal for Clinicians. 2019; 69(3): 234–247. https://doi.org/10.3322/caac.21558 Alfano, C.M., et al., Implementing personalized pathways for cancer follow-up care in the United States: Proceedings from an American Cancer Society–American Society of Clinical Oncology summit. CA: A Cancer Journal for Clinicians. 2019; 69(3): 234–247. https://​doi.​org/​10.​3322/​caac.​21558
21.
Zurück zum Zitat Pollock, M., et al., Chapter V: Overviews of reviews, in J.T. Higgins, J, Editor. Cochrane handbook for systematic reviews of interventions: Cochrane; 2019. Pollock, M., et al., Chapter V: Overviews of reviews, in J.T. Higgins, J, Editor. Cochrane handbook for systematic reviews of interventions: Cochrane; 2019.
51.
Zurück zum Zitat Mayer, D.K. and C.M. Alfano, Personalized risk-stratified cancer follow-up care: its potential for healthier survivors, happier clinicians, and lower costs. JNCI: Journal of the National Cancer Institute. 2019; 111(5): 442–448. https://doi.org/10.1093/jnci/djy232 Mayer, D.K. and C.M. Alfano, Personalized risk-stratified cancer follow-up care: its potential for healthier survivors, happier clinicians, and lower costs. JNCI: Journal of the National Cancer Institute. 2019; 111(5): 442–448. https://​doi.​org/​10.​1093/​jnci/​djy232
59.
Metadaten
Titel
Effectiveness and implementation of models of cancer survivorship care: an overview of systematic reviews
verfasst von
Raymond J. Chan
Fiona Crawford-Williams
Megan Crichton
Ria Joseph
Nicolas H. Hart
Kristi Milley
Paige Druce
Jianrong Zhang
Michael Jefford
Karolina Lisy
Jon Emery
Larissa Nekhlyudov
Publikationsdatum
16.11.2021
Verlag
Springer US
Erschienen in
Journal of Cancer Survivorship / Ausgabe 1/2023
Print ISSN: 1932-2259
Elektronische ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-021-01128-1

Weitere Artikel der Ausgabe 1/2023

Journal of Cancer Survivorship 1/2023 Zur Ausgabe

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Bessere Prognose mit links- statt rechtsseitigem Kolon-Ca.

06.05.2024 Kolonkarzinom Nachrichten

Menschen mit linksseitigem Kolonkarzinom leben im Mittel zweieinhalb Jahre länger als solche mit rechtsseitigem Tumor. Auch aktuell ist das Sterberisiko bei linksseitigen Tumoren US-Daten zufolge etwa um 11% geringer als bei rechtsseitigen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.